Transcriptional and non-transcriptional functions of IRF3 in ALD
Transcriptional and non-transcriptional functions of IRF3 in ALD
批准号:
10173028
负责人:
LAURA E. NAGY
金额:
$16.09万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-05 至 2022-06-30
关键词:
2019-nCoVAdaptive Immune SystemAddressAdult Respiratory Distress SyndromeAffectAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAntiviral AgentsAntiviral ResponseCOVID-19COVID-19 pandemicCellsCessation of lifeChronicClinicalCommunicable DiseasesCoronavirusCritical IllnessDataDatabasesDegradation PathwayDiagnosisDiseaseDisease ProgressionDouble-Stranded RNAEpidemicEthanolFailureFrequenciesFutureGeneticGenetic TranscriptionHeavy DrinkingHepatitisHospitalizationIRF3 geneImmuneIndividualLiver diseasesMasksMediatingMedicalMorbidity - disease ratePaperParentsPatientsPeripheralPeripheral Blood Mononuclear CellPrimary Health CareProspective cohort studyPublic HealthRNARNA DegradationRandomizedRegulationResearchResistance to infectionRiskRoleSeveritiesSignal TransductionTest ResultTestingUnited KingdomUpdateViralViral GenesVirus Diseasesadaptive immune responsealcohol exposurealcohol riskbiobankbioinformatics pipelineinfection riskmacrophagemonocytemortalitymouse modelnegative affectpandemic diseasephenotypic dataresponsesingle-cell RNA sequencingtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) is a highly contagious and fast-spreading infectious disease, which reached pandemic status in only four
months and is spreading worldwide with millions of people being affected. The clinical spectrum of COVID-19
ranges from mild to critically ill diseases. COVID-19 can progress rapidly into acute respiratory distress syndrome
(ARDS), multiorgan failure, and even death. In the midst of the COVID-19 epidemic, there is some evidence for
increased alcohol purchases. Since people generally buy more alcohol during epidemics, increased alcohol
consumption may result in reduced resistance to infections like COVID-19 and promote the progression of the
disease. SARS-COV-2 is a positive-sense single stranded RNA (ssRNA). While alcohol consumption has not
yet been shown to directly increase risk for SARS-COV-2 transmission or COVID-19 severity, alcohol negatively
affects the both the innate and adaptive immune systems and increases risk for many infectious diseases.
Importantly, recent data from both murine models of ethanol exposure and peripheral blood mononuclear cells
(PBMCs) from patients with alcohol-associated hepatitis (AH) indicate that signaling by viral ss/dsRNA is
disrupted by alcohol, analogous to impact of alcohol on signaling via bacterial products, such as LPS. The parent
RO-1 (Transcriptional and non-transcriptional roles of IRF3 in ALD) for this URGENT COMPETITIVE RENEWAL,
we are investigating the impact of chronic ethanol on ss/ds RNA sensing and activation of IRF3-mediated cellular
responses. Here we propose to extend the scope of this RO1 to address two important aspects of the interaction
of alcohol and COVID-19 in people consuming alcohol. In Specific Aim 1, making use of data from the UK
Biobank, we will ask whether alcohol consumption or alcohol-related diseases increase risk of infection,
hospitalization and mortality. In Specific Aim 2, we will use single cell RNA seq analysis to interrogate the impact
of alcohol consumption on anti-viral responses in peripheral innate and adaptive immune cells. Understanding
the impact of alcohol use on risk for COVID-19 and characterizing the specific cellular changes in anti-viral
responses will meet an important unmet clinical need for guiding public health and medical responses to the
COVID-19 pandemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IRAKM and MINCLE in ALD
-
批准号:10750123
-
项目类别:
-
资助金额:$60.22万
-
财政年份:2023
-
负责人:LAURA E. NAGY
-
依托单位:
Transcriptional and non-transcriptional functions of IRF3 in ALD
-
批准号:10207370
-
项目类别:
-
资助金额:$47.99万
-
财政年份:2019
-
负责人:LAURA E. NAGY
-
依托单位:
Transcriptional and non-transcriptional functions of IRF3 in ALD
-
批准号:10430300
-
项目类别:
-
资助金额:$16.09万
-
财政年份:2019
-
负责人:LAURA E. NAGY
-
依托单位:
Transcriptional and non-transcriptional functions of IRF3 in ALD
-
批准号:9765602
-
项目类别:
-
资助金额:$49.19万
-
财政年份:2019
-
负责人:LAURA E. NAGY
-
依托单位:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
-
批准号:10428502
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-sized hyaluronan: a dual targeted therapy for ALD
-
批准号:10227144
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-sized hyaluronan: a dual targeted therapy for ALD
-
批准号:9753072
-
项目类别:
-
资助金额:$40.93万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-sized hyaluronan: a dual targeted therapy for ALD
-
批准号:10457954
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
-
批准号:9791131
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-sized hyaluronan: a dual targeted therapy for ALD
-
批准号:9977058
-
项目类别:
-
资助金额:$41.19万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
-
批准号:10887780
-
项目类别:
-
资助金额:$14.16万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
-
批准号:10202399
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2018
-
负责人:LAURA E. NAGY
-
依托单位:
19th and 20th International Symposium on Cells of the Hepatic Sinusoid to be held in 2017 in Galway, Ireland and 2019 in Sydney, Australia.
-
批准号:9753846
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2017
-
负责人:LAURA E. NAGY
-
依托单位:
19th and 20th International Symposium on Cells of the Hepatic Sinusoid to be held in 2017 in Galway, Ireland and 2019 in Sydney, Australia.
-
批准号:9397881
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2017
-
负责人:LAURA E. NAGY
-
依托单位:
Alcohol and tissue injury from mechanisms to treatments
-
批准号:9262113
-
项目类别:
-
资助金额:$162.49万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-size hyaluronan in ALD
-
批准号:9207080
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
Project 4 Title: Innate immunity and cell death in ALD
-
批准号:10609544
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
Administrative Core
-
批准号:10609539
-
项目类别:
-
资助金额:$10.96万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
Specific-size hyaluronan in ALD
-
批准号:9054516
-
项目类别:
-
资助金额:$22.78万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
Alcohol and tissue injury from mechanisms to treatments
-
批准号:9900693
-
项目类别:
-
资助金额:$158.63万
-
财政年份:2016
-
负责人:LAURA E. NAGY
-
依托单位:
海外基金